Immobazyme Raises $2.9M to Expand Precision Fermentation-Based Biologics Platform
South African biotech company Immobazyme has secured R25 million (around $1.5 million) in a funding round led by the University Technology Fund (UTF II), with participation from Fireball Capital and University of Stellenbosch Enterprises (USE). The capital takes the total amount raised by Immobazyme to R50 million (around $2.9 million), following a previous raise last year. It will be used to accelerate the expansion of the company’s proprietary biologics platform, …
South Africa’s Immobazyme Raises $1.3M to Boost Production of Precision Fermentation-Derived Proteins
South Africa’s Immobazyme, a precision fermentation company spin-off from Stellenbosch University, has raised $1.3 million in a recent investment round led by the University Technology Fund (UTF) with the participation of Innovus (University of Stellenbosch Enterprises). Immobazyme develops high-value proteins for various industries, including cultivated meat. The new capital will support the company’s production expansion, which includes doubling its current facility size and scaling its platform. This round brings its total …